Transfusion‐associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow‐up. A prospective cohort study
Bueno, José L., Bocanegra, Ana B., Sánchez, Isabel, Mateos, José M., Puyuelo, Alba, García Erce, José A., Villanueva, Héctor, Reaño, María M., Núñez, Lucía, Losa, Azucena, Arias, Ana, Aguilar, Miriam, Richart, Luis A., Martínez, Fátima, Salgado, Rosario, Royuela, Ana, Cruz‐Bermúdez, Juan L., Fernández, Roberto, Forés, Rafael, Fornet, Inocencia, Ojeda, Emilio, Cabrera, Rafael, Duarte, Rafael F.
Published in Transfusion (Philadelphia, Pa.) (01.10.2023)
Published in Transfusion (Philadelphia, Pa.) (01.10.2023)
Get full text
Journal Article
Transfusion‐associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24h follow‐up. A prospective cohort study
Bueno, José L, Bocanegra, Ana B, Sánchez, Isabel, Mateos, José M, Puyuelo, Alba, García Erce, José A, Villanueva, Héctor, Reaño, María M, Núñez, Lucía, Losa, Azucena, Arias, Ana, Aguilar, Miriam, Richart, Luis A, Martínez, Fátima, Salgado, Rosario, Royuela, Ana, Juan L Cruz‐Bermúdez, Fernández, Roberto, és, Rafael, net, Inocencia, Ojeda, Emilio, Cabrera, Rafael, Duarte, Rafael F
Published in Transfusion (Philadelphia, Pa.) (01.10.2023)
Published in Transfusion (Philadelphia, Pa.) (01.10.2023)
Get full text
Journal Article